Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,574,990
-$60,230,552 QoQ
Shares Held
116,291
-93.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#206
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SATURNA CAPITAL CORP holds $1,106,352,364 across 8 Drug Manufacturers - General names. NVO ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
460,411 | $552,230,811 | |
| 2 | ABBV |
AbbVie Inc.
|
958,069 | $241,088,483 | |
| 3 | AZN |
Astrazeneca PLC
|
911,933 | $172,920,735 | |
| 4 | JNJ |
Johnson & Johnson
|
229,115 | $58,188,336 | |
| 5 | NVS |
Novartis AG
|
311,392 | $48,801,354 | |
| 6 | MRK |
Merck & Co., Inc.
|
197,643 | $25,397,125 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
116,291 | $5,574,990 | |
| 8 | GSK |
GSK plc
|
41,025 | $2,150,530 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,574,990 | 116,291 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,805,542 | 1,790,627 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $105,454,854 | 2,072,619 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $115,122,494 | 2,074,653 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $146,577,221 | 2,123,692 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $148,932,064 | 2,144,759 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $181,669,766 | 2,111,948 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $253,861,764 | 2,132,038 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $304,893,353 | 2,136,005 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $274,736,324 | 2,139,691 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $220,014,770 | 2,126,774 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $193,613,442 | 2,129,024 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $172,698,826 | 1,067,162 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $170,007,193 | 1,068,287 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $144,632,715 | 1,068,662 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $106,760,618 | 1,071,571 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $119,375,627 | 1,071,306 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $119,241,714 | 1,073,766 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $120,485,792 | 1,075,766 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $102,835,638 | 1,071,093 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $90,409,861 | 1,079,263 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $72,618,958 | 1,077,113 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $74,890,585 | 1,072,163 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $74,358,696 | 1,070,988 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $70,128,294 | 1,070,988 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $64,473,477 | 1,070,988 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||